Low-density Lipoprotein Cholesterol Level on Admission and After One Year with Clinical Outcomes in Patients Admitted with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

In a tertiary hospital large-volume ACS-PCI center, more than two-thirds of patients had their mean LDL-C level at presentation and 1-year beyond the recommended target level of <1.4 mmol/L, with one-third of patients developing 1-year MACE. A strategy of only taking a high-intensity statin was not adequate in reaching the LDL-C goal of <1.4 mmol/L though two-thirds of patient achieved 50% reduction in their LDL-C. There is an urgent need to educate physicians in the region to follow the recommended target LDL-C of 1.4 mmol/L and escalate the statin dose. In addition, there is a need to make availability of add-on anti-lipid drugs to attain this target and prevent MACE.